Stock Earnings

Question 1

Eli Lilly and Co'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Eli Lilly and Co'in toplam varlıkları $78,714 olup, net profit $10,590'dir.

Question 2

LLY'ün temel finansal oranları nelerdir?

Accepted Answer

Eli Lilly and Co'in cari oranı 1.21, net kâr marjı 23.51, hisse başına satış $49.82'dir.

Question 3

Eli Lilly and Co'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Eli Lilly and Co largest revenue segment is Glucagon, at a revenue of 32,500,000 in the most earnings release.For geography, US Revenue is the primary market for Eli Lilly and Co, at a revenue of 30,375,200,000.

Question 4

Eli Lilly and Co kârlı mı?

Accepted Answer

yes, son mali tablolara göre Eli Lilly and Co'in net profit $10,590'dir.

Question 5

Eli Lilly and Co'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Eli Lilly and Co'in yükümlülüğü 64,522'dir.

Question 6

Eli Lilly and Co'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Eli Lilly and Co'in toplam tedavüldeki hisse sayısı 947.53'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	59,419	45,042	34,124	28,541	28,318	24,539
Revenue Growth (YoY)	45%	32%	20%	1%	15%	10%
Cost of Revenue	10,084	8,418	7,082	6,629	7,312	5,483
Gross Profit	49,335	36,624	27,041	21,911	21,005	19,056
Selling, General & Admin	10,387	8,593	7,403	6,440	6,431	6,121
Research & Development	12,558	10,990	9,313	7,190	7,025	6,085
Operating Expenses	22,945	19,584	16,716	13,631	13,457	12,206
Other Non Operating Income (Expenses)	132	436	429	358	341	1,498
Pretax Income	22,503	12,680	6,554	6,806	6,155	7,229
Income Tax Expense	4,091	2,090	1,314	561	573	1,036
Net Income	18,412	10,590	5,240	6,244	5,581	6,193
Net Income Growth	120%	102%	-16%	12%	-10%	-26%
Shares Outstanding (Diluted)	898.8	904.05	903.28	904.61	911.68	912.5
Shares Change (YoY)	-1%	0%	0%	-1%	0%	-2%
EPS (Diluted)	20.48	11.71	5.8	6.9	6.12	6.79
EPS Growth	121%	102%	-16%	13%	-10%	-24%
Free Cash Flow	6,436	414	-3,152	4,600	5,387	4,470
Free Cash Flow Per Share	7.16	0.45	-3.48	5.08	5.9	4.89
Gross Margin	83.02%	81.31%	79.24%	76.77%	74.17%	77.65%
Operating Margin	44.41%	37.83%	30.25%	29.01%	26.65%	27.91%
Profit Margin	30.98%	23.51%	15.35%	21.87%	19.7%	25.23%
Free Cash Flow Margin	10.83%	0.91%	-9.23%	16.11%	19.02%	18.21%
EBITDA	28,286	18,806	11,852	9,802	9,095	8,172
EBITDA Margin	47.6%	41.75%	34.73%	34.34%	32.11%	33.3%
D&A For EBITDA	1,896	1,766	1,527	1,522	1,547	1,323
EBIT	26,390	17,040	10,325	8,280	7,548	6,849
EBIT Margin	44.41%	37.83%	30.25%	29.01%	26.65%	27.91%
Effective Tax Rate	18.17%	16.48%	20.04%	8.24%	9.3%	14.33%

Eli Lilly and Co (LLY) Price

LLY Stock Price Chart

LLY Income

Follow-Up Questions